From concept to clinic-ready protocol in two months.

When a US-based biotech needed to move a novel compound into Phase 2b for non-segmental vitiligo, they needed a medical writing team that could do more than produce documents. They needed scientific partners who could shape study design, deliver with rigour and keep their senior team focused on other priorities. That is exactly what the TFS HealthScience Medical Writing team delivered.

Inside this case study, you will discover:

• Why involving a medical writing team at the design phase rather than after can be the difference between a smooth protocol and costly amendments
• How the TFS Medical Writing team built a complete synopsis from a single slide deck in under a month, covering all elements for a Phase 2b randomised, double-blind, controlled clinical trial
• What real cross-functional support looks like when clinical, statistical and regulatory expertise are aligned from day one
• The outcome: one round of review, no major changes and a study now active with full recruitment complete

This case study is relevant to any clinical lead or head of development approaching a protocol milestone, regardless of therapeutic area.

Learn more about our related services and resources:

TFS Medical Writing